Analysts expect BioAtla, Inc. to report revenue of 0.00 for Q1 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at 6.50 M.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 11.00 M | 0.00 | 0.00 | 0.00 | 0.00 | 2.00 M | - | 6.50 M | - | - | - | - | - | - | - | |||||||||||
| High Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.51 M | 1.67 M | 641,021.13 | -172,267.38 | 12.52 M | |||||||||||
| Low Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.36 M | 1.48 M | 583,360.11 | -199,910.92 | 10.99 M | |||||||||||
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.44 M | 1.58 M | 612,190.62 | -186,089.15 | 11.76 M |
Analysts expect BioAtla, Inc. to report earnings per share of -6.66 for Q3 26, against a range of -7.17 to -6.15. The most recent reported quarter, Q2 26, came in at 0.27, a 103.1% beat against the -8.75 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -11.00 | -15.00 | -13.00 | -16.00 | -13.50 | -8.00 | -4.22 | 0.27 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -20.55 | -18.92 | -13.98 | -11.91 | -14.75 | -10.30 | -9.57 | -7.99 | -6.15 | -6.81 | -14.29 | -14.57 | -13.47 | -12.11 | -11.32 | -11.68 | ||||||||||
| Low Estimate | -21.99 | -20.68 | -15.98 | -14.53 | -16.59 | -12.22 | -11.21 | -9.51 | -7.17 | -7.91 | -16.17 | -17.43 | -15.69 | -14.19 | -13.34 | -12.90 | ||||||||||
| Consensus Estimate | -21.27 | -19.80 | -14.98 | -13.22 | -15.67 | -11.26 | -10.39 | -8.75 | -6.66 | -7.36 | -15.23 | -16.00 | -14.58 | -13.15 | -12.33 | -12.29 |
Pull Wall Street consensus for BioAtla, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=BCAB&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "BCAB", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=BCAB&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();